VEGFA and dementia: From this pool of ICSRs for intravitreal anti-VEGF drugs, 27 (0.33%) were identified concerning the narrow SMQs for “Parkinson-like events” and “Dementia” which were potentially related to intravitreal anti-VEGF drugs.